Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04108858
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8HER2-Positive Breast CarcinomaMetastatic Breast Carcinoma
National Cancer Institute (NCI) 2
Early research (Phase 1)WithdrawnNCT06357858
What this trial is testing

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Case Comprehensive Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT06743555
What this trial is testing

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 14
Testing effectiveness (Phase 2)Looking for participantsNCT06356155
What this trial is testing

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Michigan Rogel Cancer Center 32
Not applicableEnded earlyNCT06419478
What this trial is testing

Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis

Who this might be right for
Patients With Primary Liver Cancer (PLC) Undergoing Curative Surgical ProceduresImportance of Identifying Core Symptoms for Improving Symptom Management in PLC PatientsApplication of Network Analysis as a Crucial Component of Cancer Care
Mengmeng Yuan 249
Not applicableLooking for participantsNCT06835426
What this trial is testing

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Who this might be right for
Breast CarcinomaProstate Cancer SurgeryThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares 150
Testing effectiveness (Phase 2)Study completedNCT01037998
What this trial is testing

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 115
Testing effectiveness (Phase 2)Study completedNCT00068393
What this trial is testing

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaRenal Cell Carcinoma With Sarcomatoid Features
Eastern Cooperative Oncology Group 39
Not applicableStudy completedNCT06607393
What this trial is testing

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

Who this might be right for
Metastatic Nonsmall Cell Lung Cancer
Aetion, Inc. 851
Early research (Phase 1)UnknownNCT06225921
What this trial is testing

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Who this might be right for
Esophageal Squamous Cell Carcinoma
West China Hospital 6
Testing effectiveness (Phase 2)WithdrawnNCT02336984
What this trial is testing

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Very early researchEnded earlyNCT02827838
What this trial is testing

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Study completedNCT00230126
What this trial is testing

OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ohio State University Comprehensive Cancer Center 57
Testing effectiveness (Phase 2)Ended earlyNCT02479178
What this trial is testing

BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Urothelial CarcinomaCholangiocarcinomaCervical Cancer+1 more
BIND Therapeutics 73
Not applicableStudy completedNCT05435885
What this trial is testing

Postoperative Telerehabilitation in Older Adults

Who this might be right for
TelerehabilitationCarcinoma, Non-Small-Cell LungCardiopulmonary Exercise Test
Pusan National University Hospital 64
Not applicableUnknownNCT02526043
What this trial is testing

Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 180
Large-scale testing (Phase 3)Study completedNCT00061815
What this trial is testing

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 102
Large-scale testing (Phase 3)Study completedNCT02234115
What this trial is testing

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

Who this might be right for
Prostatic Neoplasms
Foresee Pharmaceuticals Co., Ltd. 137
Testing effectiveness (Phase 2)Study completedNCT01222936
What this trial is testing

LBH Phase II in Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma
Southern Europe New Drug Organization 21
Testing effectiveness (Phase 2)Study completedNCT00318136
What this trial is testing

Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 47
Next Page